Healthcare

Lexeo Therapeutics (NASDAQ:LXEO) announced that the U.S. Food and Drug Administration has granted Regenerative Medicine Advanced Therapy designation to LX2020, its investigational gene therapy candidate for PKP2-associated arrhythmogenic cardiomyopathy. The designation is based on recent interim clinical data from the ongoing HEROIC-PKP2 Phase I/II …

CVS Health (NYSE:CVS) shares fell more than 4% in today's trading session even as the company reported second-quarter revenue of 106.1 billion dollars, up 7.3% from 98.9 billion dollars a year earlier, with adjusted earnings per share of 2.58 dollars topping analyst estimates and …

Waters Corporation (NYSE: WAT) has announced second-quarter earnings of $3.05 per share for the period ending July 4, 2026, slightly surpassing the consensus estimate of $3.04. The strong performance highlights the company's strong positioning in the market, with growing momentum driving positive results across …

Procept BioRobotics has been downgraded by William Blair due to perceived weaknesses in surgical procedures associated with its products. The firm’s analysis suggests that recent performance metrics around these procedures are insufficient to support continued investment support. A decline in investor confidence could result …

The company's adjusted diluted earnings per share registered at $(0.07), a stark contrast to the consensus expectation of $0.44, highlighting significant performance issues that may concern investors. These results reflect ongoing pressures within USANA's operational segments, especially in emerging ventures like Hiya and Rise …

The company's year-to-date performance stands out with an impressive gain of 173.4%, although it has faced a 15.4% decline over the past month. The market capitalization currently stands at approximately $4.3 billion, positioning Veradermics as a noteworthy player in the healthcare sector. This growth …

Leadership Transition and Market Position